NM_001278293.3:c.362G>A
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP5
The NM_001278293.3(ARL6):c.362G>A(p.Arg121His) variant causes a missense change. The variant allele was found at a frequency of 0.0000161 in 1,613,060 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001278293.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250632Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135482
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1460932Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 726790
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74318
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26355662, 27124789, 33090715, 28130426, 28005406) -
- -
Bardet-Biedl syndrome 3;C3150808:Retinitis pigmentosa 55 Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 121 of the ARL6 protein (p.Arg121His). This variant is present in population databases (rs765715798, gnomAD 0.007%). This missense change has been observed in individuals with clinical features of ARL6-related conditions (PMID: 26355662, 28130426, 35457050; Invitae). ClinVar contains an entry for this variant (Variation ID: 191178). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the p.Arg121 amino acid residue in ARL6. Other variant(s) that disrupt this residue have been observed in individuals with ARL6-related conditions (PMID: 33090715), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Autosomal recessive retinitis pigmentosa Pathogenic:1
- -
Bardet-Biedl syndrome 3;C2936862:Bardet-Biedl syndrome 1;C3150808:Retinitis pigmentosa 55 Pathogenic:1
- -
Bardet-Biedl syndrome Pathogenic:1
Variant summary: ARL6 c.362G>A (p.Arg121His) results in a non-conservative amino acid change located in the small GTP-binding protein domain (IPR005225) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 250632 control chromosomes (gnomAD). The variant, c.362G>A, has been reported in the literature in at least three homozygous individuals affected with retinal dystrophy (Patel_2016, Abouelhoda_2016, Biswas_2017, Ramkumar_2017, Gonzalez-Iglesias_2022). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. A different missense change affecting the same amino acid (c.361C>T (p.R121C)) is reported in individual(s) affected with retinal dystrophy (HGMD), suggesting a functional role for this residue. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014, and classified the variant as pathogenic (n=1) and uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at